Skip to main content

Choking Hazard Spurs Recall of Bath Toys Sold at Target

Medically reviewed by Drugs.com.

By Physician’s Briefing Staff HealthDay Reporter

FRIDAY, Sept. 15, 2023 -- The Chuckle & Roar Ultimate Water Beads Activity Kit, a child's toy made by Buffalo Games and sold exclusively at Target, is being recalled due to serious ingestion, choking, and obstruction hazards after one infant died and another was injured and required surgery.

Together, the U.S. Consumer Product Safety Commission (CPSC) and Buffalo Games LLC, of Buffalo, New York, announced the recall of about 52,000 of the kits on Thursday. Consumers can contact Buffalo Games for a full refund and instructions on how to return the product in a prepaid mailing package. Another option is to return the product to any Target store.

The hazard is that if one of these water beads is ingested, it expands. It can then cause choking and obstruction inside a child's body. This could lead to severe discomfort, vomiting and dehydration, and even death.

A 10-month-old died in July in Wisconsin after swallowing water beads. A 9-month-old in Maine was seriously injured in November after swallowing the water beads caused an intestinal obstruction, requiring surgery to remove them.

Consumers should immediately stop using the recalled water bead kits and take them away from children, the CPSC said.

The kits were sold exclusively at Target from March 2022 through November 2022 for about $15. They were manufactured in China. On the front of the purple container, the label reads "Ultimate Water Beads Activity Kit." It has the UPC Number 079346627035 on the back.

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

ADA: Bisphenol A Linked to Reduced Peripheral Insulin Sensitivity

THURSDAY, June 27, 2024 -- Bisphenol A (BPA) administration is associated with reduced peripheral insulin sensitivity among healthy adults, according to a study presented at the...

COVID-19 Vaccination Not Tied to Adverse Pregnancy Outcomes

TUESDAY, June 25, 2024 -- mRNA COVID-19 vaccination during pregnancy is not associated with an increased risk of adverse pregnancy outcomes, according to a study published in the...

NT-proBNP, IL-1RL Can Identify High-Risk Congenital Heart Disease in Neonates

MONDAY, June 24, 2024 -- Automated quantitative tests for NT-proBNP and interleukin 1 receptor-like 1 (IL-1 RL1) can identify high-risk congenital heart disease (CHD) in newborns...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.